Core Viewpoint - The company, Narui Radar (688522.SH), expects significant growth in revenue and net profit for the fiscal year 2025, driven by strong demand and successful contract acquisitions in various sectors [1] Financial Performance - The company anticipates achieving approximately 460 million yuan in operating revenue for 2025, representing an increase of about 115 million yuan, or a year-on-year growth of approximately 33.26% [1] - The projected net profit attributable to the parent company is around 118 million yuan, which is an increase of approximately 41.5 million yuan, reflecting a year-on-year growth of about 54.16% [1] - The expected net profit attributable to the parent company after deducting non-recurring gains and losses is estimated at around 108 million yuan, indicating an increase of approximately 21.9 million yuan, or a year-on-year growth of about 25.52% [1] Growth Drivers - The primary reasons for the performance changes include the company's advantages in product technology and brand recognition, which have led to increased acceptance among clients across different fields [1] - There has been a significant increase in the contract amount for new water conservancy and rain radar projects, contributing to the substantial growth in operating revenue [1] - The acceleration in the confirmation and realization of existing orders has further propelled the company's rapid revenue growth and enhanced profitability [1]

南财智讯1月30日电，星辉娱乐发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 27000万元—35100万元，同比预增158.99%—176.68%；预计2025年全年归属于上市公司股东的扣除非 经常性损益的净利润为21700万元—28210万元，同比预增146.66%—160.66%。业绩变动原因说明：报 告期内公司各业务经营情况如下：（1）玩具业务方面，公司在报告期积极推动产品结构升级与渠道深 度布局，稳步扩张全球市场版图，产品竞争力持续提升，净利润保持稳定增长。（2）游戏业务方面， 报告期内《冒险岛R：进化》《仙境传说：破晓》《战地无疆》《三国群英传：策定九州》等多款游戏 产品于境内外陆续上线，效益逐步释放，带动收入同比大幅增长并实现扭亏为盈。（3）足球俱乐部业 务方面，报告期内，西班牙人俱乐部各项收入增长并实现扭亏为盈；此外，为进一步聚焦核心业务，优 化资源配置，减少未来盈利的不确定性，公司出售了西班牙人俱乐部99.66%股权，剥离了足球俱乐部 业务，进一步增厚公司业绩。（4）公司预计2025年度非经常性损益对利润的影响额约为5372.58万元， 上年同期金额为732.27万元。 ...

祖名股份公告称，2025年预计实现营业收入20.00-20.50亿元，同比增长20.16%-23.17%；归属于上市公 司股东的净利润2500-3200万元，同比增长199.46%-227.31%，实现扭亏为盈；扣除非经常性损益后的净 利润亏损3600-4300万元。业绩变动主因是南京果果豆制食品确认商誉减值、调整股权转让款及扬州祖 名豆制食品收到拆迁款。公司积极拓市场，产销量增加，盈利能力逐步恢复。 ...

每经AI快讯，1月30日，赛诺医疗(688108.SH)公告称，预计2025年归属于上市公司股东的净利润为4300 万元至5000万元，较上年同期增加4150万元至4850万元，同比增长2767%至3233%。业绩增长主要因冠 脉及神经介入业务收入增长、营业成本和管理费用小幅增长、销售费用及研发费用下降、资产减值损失 大幅减少，叠加上年同期净利润基数较小。 ...

Core Viewpoint - The company expects to achieve a net profit attributable to shareholders of approximately 118 million yuan for the fiscal year 2025, representing an increase of about 41.5 million yuan compared to the previous year, which is a year-on-year growth of approximately 54.16% [1] Group 1 - The company has gained recognition from clients across various sectors due to its product technology and brand advantages [1] - The contract amount for newly signed hydrological radar projects has significantly increased [1] - The acceleration of confirming existing orders has led to a substantial growth in operating revenue, maintaining rapid performance growth and significantly enhancing profitability [1]

宏微科技公告称，预计2025年年度归属于母公司所有者的净利润为1400万元至2100万元，较上年同期增 加2846.73万元至3546.73万元，同比增加196.77%至245.15%，实现扭亏为盈；扣非净利润为800万元至 1200万元，同比增加123.54%至135.30%。业绩增长主因行业景气度回升，公司拓展业务、丰富客户结 构，且资产减值损失计提金额减少。 ...

本报讯(记者吴奕萱见习记者王楠)1月30日，宁波金田铜业(集团)股份有限公司(以下简称"金田股份 （601609）")发布2025年度业绩预告，公司预计全年实现归母净利润7亿元至8亿元，同比增长51.50%至 73.14%；实现扣非归母净利润4.40亿元至5.28亿元，同比增长29.95%至55.94%。 对于业绩增长原因，金田股份在公告中表示，核心源于三大举措。一是公司持续推进"产品、客户双升 级"，深化新能源、高端装备等高附加值领域布局；二是海外市场拓展成效显著，销量与业务占比稳步 提升；三是数字化建设优化管理流程，经营效率与资产运营质量同步改善，带动产品毛利和整体盈利能 力提升。 此外，公司控股股东计划自1月30日起12个月内，以自有及自筹资金增持5000万元至1亿元公司股份，且 未设定价格区间。 同日，金田股份同步推出资本动作，计划在董事会审议通过回购方案后的12个月内(2026年1月27日至 2027年1月26日)，以自有资金及银行专项贷款回购A股股份，资金规模为2亿元至4亿元，回购价格上限 16.84元/股，用于可转债转换。 ...

新东方-S（09901）午前股价上涨3.22%，报47.52港元，成交额1.70亿港元。 新东方日前发布截至2025年11月30日止的2026财年第二季度财务业绩公告，净营收同比上升14.7%至 11.91亿美元；经营利润同比上升244.4%至6630万美元；股东应占净利润同比上升42.3%至4550万美元。 公司上调2026财年全年净营收指引至52.92-54.88 亿美元，同比增长8%-12%。 摩根大通发布研报称，重申新东方"增持"评级及首选股份地位，目标价由53港元升至55港元。新东方 2026财年第二财季业绩好于预期，并上调指引，这是两年来的首次。管理层的乐观态度促使该行将2026 财年至2027财年的经营利润预测上调7%。 责任编辑：卢昱君 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 摩根大通发布研报称，重申新东方"增持"评级及首选股份地位，目标价由53港元升至55港元。新东方 2026财年第二财季业绩好于预期，并上调指引，这是两年来的首次。管理层的乐观态度促使该行将2026 财年至2027财年的经营利润预测上调7%。 责任编辑：卢昱君 热点栏目 自选股 数据中心 行情中心 资金流向 ...

摩根大通发布研报称，重申新东方"增持"评级及首选股份地位，目标价由53港元升至55港元。新东方 2026财年第二财季业绩好于预期，并上调指引，这是两年来的首次。管理层的乐观态度促使该行将2026 财年至2027财年的经营利润预测上调7%。 智通财经APP获悉，新东方-S(09901)再涨超3%，截至发稿，涨3.13%，报47.48港元，成交额1.67亿港 元。 消息面上，新东方日前发布截至2025年11月30日止的2026财年第二季度财务业绩公告，净营收同比上升 14.7%至11.91亿美元；经营利润同比上升244.4%至6630万美元；股东应占净利润同比上升42.3%至4550 万美元。公司上调2026财年全年净营收指引至52.92-54.88 亿美元，同比增长8%-12%。 ...

Core Viewpoint - The company Baidu Biotechnology (02315) has announced a positive earnings forecast for the fiscal year 2025, leading to a significant increase in its stock price by nearly 13% following the announcement [1] Financial Performance - The company expects to achieve revenue of approximately 1.369 billion to 1.389 billion yuan, representing an increase of 389 million to 408 million yuan compared to the previous year, with a year-on-year growth rate of 39.61% to 41.65% [1] - The anticipated net profit attributable to shareholders is projected to be around 162 million to 182 million yuan, which is an increase of 129 million to 149 million yuan from the previous year, indicating a substantial year-on-year growth of 384.26% to 443.88% [1] Market Dynamics - The company's revenue growth is attributed to the continuous expansion in overseas markets, coupled with a recovery in the domestic biopharmaceutical industry [1] - The high barriers to entry in technology have helped maintain high gross margins, while lean management initiatives have further enhanced operational efficiency, leading to a rapid increase in profitability [1]